We sought to examine mechanisms responsible for increased vasoconstriction that occurs during development of nitroglycerin tolerance. Rabbits were treated for 3 days with nitroglycerin patches (0.4 mg/hr), and their aortic segments were studied in organ chambers. This treatment resulted in attenuated in vitro relaxations to nitroglycerin and increased contractile sensitivity to angiotensin II, serotonin, phenylephrine, KCI, and a direct activator of protein kinase C, the phorbol ester phorbol 12,13-dibutyrate. The protein kinase C antagonists calphostin C (100 nM) and staurosporine (10 nM) corrected the hypersensitivity to constrictors in tolerant vessels, yet had minimal effects on constrictions in control vessels. Paradoxically, constrictions caused by endothelin 1 were decreased in nitrate-tolerant vessels. Immunocytochemical analysis revealed intense endothelin 1-like and big endothelin 1-like immunoreactivity in the media of nitroglycerin-tolerant but not of control aortas. The enhanced vasoconstriction to angiotensin II, serotonin, KCI, and phenylephrine could be mimicked in normal vessels by addition of subthreshold concentrations of endothelin 1, and this effect was prevented by calphostin C. We propose that increased autocrine production of endothelin 1 in nitrate tolerance sensitizes vascular smooth muscle to a variety of vasoconstrictors through a protein kinase C-mediated mechanism.
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Chronic administration of organic nitrates invariably leads to the rapid development of nitrate tolerance (for review, see refs. 1 and 2). Traditional explanations for nitroglycerin tolerance have focused on mechanisms such as neurohumoral adaptations (3, 4) , impaired nitroglycerin biotransformation to nitric oxide (5) , or desensitization of the vascular smooth muscle target enzyme guanylyl cyclase (6) . Recently, we have demonstrated that nitroglycerin tolerance is associated with an increase in vascular superoxide anion production, which likely inactivates endogenously released nitric oxide and nitric oxide released from exogenously applied nitrovasodilators (7). Together, these multiple mechanisms may account for decreased nitroglycerin-induced vasodilatation after its prolonged administration.
Much less attention has been devoted to the possible role of enhanced vasoconstriction in nitrate tolerance. Previous studies have shown that long-term treatment with high doses of nitroglycerin is associated with an increase in sensitivity to a-adrenergic stimuli (8, 9) . Further, abrupt cessation of nitrate therapy often leads to rebound vasoconstriction (10) , which may be due to an increased sensitivity of the nitrate-tolerant vasculature to endogenous vasoconstrictors. The mechanisms underlying these phenomena remain obscure.
In the present study we sought to determine whether chronic nitroglycerin treatment, in clinically relevant concentrations,
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. FIG. 1. Effects of 3 days of nitroglycerin treatment on sensitivity to Ang-I1 (A), phenylephrine (PE) (B), 5-HT (C), and KCI (D). Nitrate tolerance was associated with an increase in sensitivity to all constrictors, which was largely corrected by calphostin C (100 nM). Each value represents the mean ± SEM of 8-13 experiments, except for calphostin C, which represents 5-7 experiments. *, Control; A, control + 10-7 M calphostin C; 0, nitrate tolerant; a, nitrate tolerant + 10-7 M calphostin C. *, ECQo (P < 0.05 vs. control). t, Maximum constriction (P < 0.05 vs. tolerant).
increases sensitivity to constrictors and to examine mechanisms potentially responsible for this phenomenon.
METHODS AND MATERIALS
Animal Model. New Zealand White rabbits of either sex (weight = 3-6 kg) were studied. A region either on the dorsal aspect of the thorax or between the scapulae was shaved, and a nitroglycerin patch was applied to the skin. The nitroglycerin patch was changed each morning for 2 days. On the morning of the third day, an i.v. injection of 100 units of heparin was administered, followed by a lethal dose of pentobarbital. The chest was then rapidly opened, and the descending thoracic aorta was removed. Rabbits of a similar size and sex served as controls.
Vessel Preparation and Organ Chamber Experiments. Organ chamber studies were done as described (7) . Relaxations to nitroglycerin were evoked after the vessels were submaxiAbbreviations: PBt2, phorbol 12,13-dibutyrate; Ang-II, angiotensin II; 5-HT, serotonin; PKC, protein kinase C.
§To whom reprint requests should be addressed at: Cardiology Division, Emory University School of Medicine, P.O. Drawer LL, Atlanta, GA 30322. 13 ). Pretreatment of nitroglycerin-tolerant aortas for 1 hr with either calphostin C (100 nM) or staurosporine (10 nM) normalized contractions caused by either Ang-II, phenylephrine, 5-HT, or KCl. In contrast, these PKC inhibitors had only modest or no effect on constrictions to these vasoconstrictor agents in normal vessels ( Fig. 1 and Tables 1 and 2 ). In addition, constrictions induced by a direct activator ofPKC, the phorbol ester PBt2, were markedly enhanced in tolerant aortic segments (Fig. 2) .
Effect of Nitrate Tolerance on Constrictions Caused by Endothelin 1. In contrast to the findings with other vasoconstrictors, responses to endothelin 1 were attenuated in aortic segments from nitroglycerin-treated animals as compared with those from control animals (Fig. 3) .
Endothelin 1 and Big Endothelin 1 Localization in Normal and Tolerant Vessels. Immunocytochemical analysis of control rabbit aortas revealed no endothelin 1-like immunoreactivity staining of the media (Fig. 4) . In contrast, the aorta of nitro- glycerin-treated animals showed intense endothelin 1 staining. Similar findings were observed for big endothelin 1-like immunoreactivity (Fig. 4) threshold concentrations of endothelin 1 (3 x 10-10 M) for 10 min before and during administration of KCI, phenylephrine, Ang-1I, and 5-HT markedly enhanced constriction to each of these agents. This increased sensitivity to these constrictors caused by endothelin 1 was prevented by calphostin C addition (Fig. 5) (17) .
The mechanism whereby nitrate tolerance could increase local endothelin 1 production remains unclear. In cultured vascular smooth muscle, low concentrations of Ang-II induce expression of pre-pro-endothelin mRNA via stimulation of the Ang type-1 receptor in a PKC-dependent mechanism (18, 19) .
The renin/angiotensin system is activated during nitrate therapy (20) and may, therefore, contribute to stimulation of vascular smooth muscle endothelin 1 expression.
What is the link between increased local endothelin concentrations and increase in sensitivity to constrictors? In the present studies we found that threshold endothelin 1 concentrations (3 x 10-10 M) markedly enhanced constrictions caused by Ang-I1, 5-HT, KCl, and phenylephrine. These findings agree with previous studies in human coronary arteries showing that threshold concentrations of endothelin may markedly enhance vasoconstrictions caused by 5-HT and norepinephrine (21) .
Similarly, Henrion and Laher (22) have shown that endothelin 1 potentiates norepinephrine-induced contractions in rabbit aorta and that this effect can be prevented by PKC inhibition. On the basis of our current findings and these prior studies, it is likely that endothelin 1, either acutely added to vessels or expressed in the vascular media during nitroglycerin treatment, enhances constrictions to many vasoconstrictor agents via activation of PKC.
A role of PKC in augmenting vasoconstriction in nitratetolerant vessels is compatible with accumulating information regarding its role in modulating vascular tone. Myogenic tone is decreased by PKC inhibition (23) and increased by PKC activation (24) . Phorbol esters convert the transient constrictions caused by Ang-II in rat aorta to sustained responses (25) . The mechanisms responsible for these phenomena remain uncertain. Activation of one or more of the vascular smooth muscle isoforms of PKC results in phosphorylation of several contractile proteins-including myosin light and heavy chains (26, 27) , myosin light chain kinase (28) , and the intermediate filaments desmin, synemin, and caldesmon (29) . Activation of voltage-gated calcium channels has also been implicated (30) . Redistribution of the thin-filament calponin among cytoskeletal structures after a-adrenergic stimulation also depends on PKC (31) . An important consequence of these events is that the contractile response to any given level of intracellular calcium is increased (24, 32) . In several cell types, stimulation of PKC by phorbol esters leads to activation of phospholipase C and accumulation of diacylglycerol, which may further activate PKC in a positive feedback fashion (33) .
We conclude that chronic nitroglycerin treatment increases endothelin 1 levels within the vascular smooth muscle. This increase in vascular endothelin 1 serves as a "priming" stimulus for PKC which, in turn, mediates hypersensitivity to a variety ofvasoconstrictor stimuli. At least two other conditions of altered vascular reactivity, advanced atherosclerosis, and pulmonary hypertension (12, 34) are also associated with increased vascular levels of endothelin 1. Thus, nitrate tolerance may share with these diseases a common mechanism underlying increased sensitivity to vasoconstrictor stimuli.
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